premargin

9574 Ratios - Professional Medical Expertise Co. | premargin

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual Quarterly

Ratios

1-5

	H1 2025Jun 30, 2025	H2 2024Dec 31, 2024	H1 2024Jun 30, 2024	H2 2023Dec 31, 2023	H1 2023Jun 30, 2023
Market & Price
Market Capitalization	308.00M	314.65M	280.00M	250.25M	—
Market Cap Growth	+10.0%	+25.7%	—	—	—
Enterprise Value	396.91M	408.61M	343.41M	321.49M	—
Last Close Price	88.00	88.85	79.07	67.81	—
Valuation Multiples
PE Ratio	8.18	11.38	10.08	10.07	—
PS Ratio	0.87	1.01	1.01	1.00	—
PB Ratio	2.34	2.78	2.82	2.58	—
P/TBV Ratio	2.34	2.78	2.82	2.58	—
P/FCF Ratio	—	-37.21	—	-80.75	—
P/OCF Ratio	23.10	-167.36	—	42.56	—
EV/Sales Ratio	1.12	1.31	1.23	1.29	—
EV/EBITDA Ratio	7.52	9.61	8.42	8.68	—
EV/EBIT Ratio	8.37	10.86	9.46	9.72	—
EV/FCF Ratio	—	-48.33	—	-103.74	—
Leverage & Capital
Debt / Equity Ratio	0.84	0.83	1.02	0.66	1.00
Debt / FCF Ratio	—	-11.10	—	-20.77	—
Net Debt / Equity Ratio	0.79	0.79	0.95	0.65	0.99
Net Debt / EBITDA Ratio	1.97	2.09	2.30	1.71	2.08
Net Debt / FCF Ratio	-80.09	-10.52	-16.84	-20.46	24.10
Returns & Yields
Return on Capital Employed (ROCE)	+32.1%	+29.7%	+32.8%	+30.6%	+38.2%
Earnings Yield	+12.2%	+8.8%	+9.9%	+9.9%	—
FCF Yield	-0.4%	-2.7%	-2.0%	-1.2%	—
Buyback Yield / Dilution	—	—	—	+0.8%	-273.1%
Total Shareholder Return	—	—	—	+0.8%	-273.1%